
Google takes a gamble in class action jury trial over cell phone data use
Tired of too many ads?
Remove Ads
Tired of too many ads?
Remove Ads
Tired of too many ads?
Remove Ads
Class actions rarely go to trial, which is why a case against Google is proving to be an outlier. The tech giant is defending itself before a jury in Santa Clara County, California, superior court in an $800 million lawsuit by Android smartphone users who say Google misappropriates their cellphone data.A jury of eight women and four men was seated on Tuesday in what lawyers say is expected to be a three-to-four-week trial, with opening statements kicking off on Wednesday.The stakes are high, but the class, which includes an estimated 14 million Californians whose mobile devices use Google's Android operating system, is in some ways just an appetizer. The same plaintiffs lawyers from Korein Tillery; Bartlit Beck and McManis Faulkner are litigating a parallel case in San Jose federal court covering Android users in the other 49 states, with billions of dollars in alleged damages.The plaintiffs in court papers say that even when their phones are turned off, Google causes Android devices to surreptitiously send information over cellular networks "for Google's own purposes," including targeted digital advertising. These transfers improperly eat up data that users purchase from their mobile carriers, the plaintiffs allege.Google spokesperson Jose Castaneda said the claims "mischaracterize standard industry practices that help protect users and make phones more reliable," he told me. "We look forward to making our case in court."A unit of Mountain View, California-based Alphabet, Google has a well-used playbook for settling class actions.Earlier this week, for example, the company agreed to pay $500 million to resolve shareholder litigation - a move that comes on the heels of a $50 million deal in May to resolve class-wide allegations of racial bias against Black employees and a $100 million payout in March to a proposed class of advertisers who claimed they were overcharged for clicks on ads.So why is Google taking this case to trial?In court papers, Google's outside counsel from Cooley argue that Android users incurred no actual losses, and that consumers consented to Google's so-called "passive" data transfers via terms of service agreements and device settings. The lawyers also dispute the fundamental premise of the case: that cellular data allowances can be considered "property" under California law and subject to conversion, a civil cause of action that involves taking a person's property without permission.When the "rhetoric and hyperbole are set aside, Plaintiffs' theory is revealed as little more than a (misguided) product design claim - not wrongful conversion," defense counsel wrote.The Cooley team, which includes Whitty Somvichian, Michael Attanasio, Max Bernstein and Carrie Lebel, declined comment.The plaintiffs sued Google in Santa Clara County Superior Court in 2019, asserting that they have a property interest in their cellular plans' data allowances, and that each quantum they pay for has a market value.They don't object to data transmissions when they're actively engaged with Google's apps and properties, like checking email or playing a game. But they say Google never told them it would avail itself of their cellular data when they weren't using their phones to send and receive a range of information on their usage."The upshot is that these phone users unknowingly subsidize the same Google advertising business that earns over $200 billion a year," plaintiffs lawyer George Zelcs of Korein Tillery said via email.In addition to injunctive relief, the plaintiffs want Google to reimburse them for the value of the cellular data the company consumed. Per person, the amount is modest - 1 to 1.5 megabytes of data each day, the plaintiffs estimate. To put that in context, Americans used just over 100 trillion megabytes of wireless data in 2023, my Reuters colleagues reported.But with a class period dating back to 2016, the totals add up quickly. In court papers, Google lawyers sound almost incredulous at the amount of the claimed nationwide damages, which they say runs in the tens of billions - more than the $7.4 billion Perdue Pharma settlement for the opioid crisis, they note. "Plaintiffs cannot show remotely commensurate harm to the class," they wrote.In denying Google's motion for summary judgment in May, Judge Charles Adams allowed the plaintiffs' claim for conversion to go forward, ruling there are triable issues of material fact for jurors to decide.While Adams said no direct state law precedent exists as to whether cell phone data is property, he pointed to a decision by the 9th U.S. Circuit Court of Appeals last year in the parallel federal class action, Taylor v Google.In that case, U.S. Magistrate Judge Virginia DeMarchi in San Jose sided with Google and dismissed the complaint with prejudice in 2022, only to be reversed and remanded on appeal.The appellate panel in an unpublished decision ruled that the plaintiffs plausibly alleged they incurred damages when Google used their cellular data.Adams in a pre-trial order set some limits on what the lawyers will be allowed to argue to the jury.Plaintiffs may not suggest Google engages in "surveillance" of Android users, he wrote, or that the data transfers are a privacy violation.As for Google, Adams said, it "must not present evidence or argument suggesting that this case is 'lawyer driven' or was 'invented' by Plaintiffs' counsel."
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Time of India
8 minutes ago
- Time of India
AI-assisted coding is the way to go when hiring graduates: LTIMindtree CEO
Academy Empower your mind, elevate your skills Hiring for freshers or entry-level graduates will have artificial intelligence or AI-assisted coding as part of the improvised assessment as the correlation between revenue and headcount growth becomes more de-linear, said chief executive officer (CEO) of the sixth-largest Indian IT company, LTIMindtree 'We are very optimistic about continuing our effort in inducting freshers. We added 1,600 freshers this quarter and we are going to add more throughout this year as well. AI-assisted coding is the way to go about it,' said Venugopal Lambu Lambu said there was more emphasis in terms of the learning ability, and the foundational skill sets that freshers have on which companies can build, using their training and learning methods.'So those assessments will always improvise it…Whenever we hire people, we take all those aspects, whether it is related to the coding roles, cloud roles or infrastructure roles or data roles,' he on freshers by building a pyramid-style organisation structure has been key for the over-$283-billion outsourcing industry's services delivery model. However, over the past more than a year, since AI took centre-stage entry-level jobs and hiring at technology firms was impacted with companies coding 20-25% via AI, reducing the need for junior-level human AI technology permeates across functions and solutions, Lambu believes there is a correlation or a non-linearity in the revenue growth and workforce addition.'Over the last few quarters, when we added revenue, the headcount has not necessarily increased. So, there is a correlation or a non-linearity, but it is too early to call out to what extent it will happen,' he added. LTIMindtree , formed with the merger of L&T Infotech and Mindtree in November 2022, last week reported a 5.2% year-on-year growth in the first quarter revenue of fiscal year 2026 at $1.15 billion. It was a 1.97% sequential rise boosted by healthy growth from Europe and its consumer or retail transitioned to take over the Mumbai-headquartered Larsen & Toubro (L&T) subsidiary's top seat on May 31, after induction into the firm in company announced its largest deal with a US-based client worth $450 million in the first quarter.'We are on the verge of signing a couple of deals, and one of them will actually beat our own record. That gives me the confidence that we will move towards the double-digit growth at some time in the second half of the year,' Lambu IT industry has been struggling with low single-digit to flat business growth over the past two years after more than two decades of strong double-digit revenue growth tariff-led macro uncertainties and the AI-backed efficiencies increase cost pressures, most software service providers are witnessing a demand contraction from top clients. This is lowering revenue contribution from large deals, a key vector for IT firms' growth.'Our contribution of top clients' revenue decreased because it has moved to the other categories. For example, we added two new $50 million-plus accounts on-year basis…The portfolio mix also is changing as we start building larger deals,' Lambu we are betting big on AI, Lambu said, AI will be net positive for both revenue and margin growth, which it expects to be closer to 16% in the next couple of quarters from 14.3% in the June quarter.


Time of India
an hour ago
- Time of India
Staff shortage in DICs hits promotion of MSME schemes
1 2 Koraput: Staff shortage in the District Industries Centre (DIC), Koraput, is affecting the implementation of govt schemes and outreach activities meant to boost entrepreneurship among unemployed youth. Official data revealed that 10 out of 14 sanctioned posts of assistant industries officers (AIOs) are vacant, severely limiting operations. Ideally, every block is supposed to have at least one AIO to raise awareness about various govt schemes aimed at promoting micro, small and medium enterprises (MSMEs). However, only four posts are filled currently, with one officer managing multiple blocks simultaneously. Most of their time is spent at the district office occupied with official work. The shortage has hampered field-level engagement and awareness drives. The impact of the administrative vacuum shows as only two persons applied for capital subsidies under MSME schemes this year — an alarmingly low number that experts attributed to poor information dissemination and lack of guidance from field officials. "This is in stark contrast to the govt's emphasis on promoting self-employment and MSMEs among youth in tribal and rural belts like Koraput. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Up to 70% off | Shop Sale Libas Undo AIOs are key personnel in promoting and implementing the govt schemes. But with most of the posts lying vacant, the efforts are falling short," said Ajit Pata, a Koraput-based activist. Two posts of assistant managers are also lying vacant in the DIC, creating bottlenecks in the implementation and monitoring of schemes. "There is certainly a shortage of staff, and it has affected scheme implementation to some extent," said general manager of DIC (Koraput), Chinmayee Parida. "However, we are doing our best with the limited resources. We are hopeful that additional staff will be recruited by Oct," he added. "Unless the vacancies are urgently filled, many potential entrepreneurs may continue to miss out on vital govt support. The gap between policy intent and ground-level execution has to be resolved soon to strengthen the DIC's field presence," said Bhabani Mishra, another activist.


Time of India
an hour ago
- Time of India
Brookfield, EQT Close In on Gland Pharma, but Rising Stock a Pain
Live Events Buyout groups Brookfield and EQT are in active discussions to buy Hyderabad-based Gland Pharma, a contract development and manufacturing organisation (CDMO) and injectables company, from China's Fosun Group in what could become one of the largest buyouts of the year in the segment, said people in the know. However, the galloping share price of Gland is a potential deal two private equity groups have been shortlisted after the initial round of bids earlier this such as CVC Capital Partners are also exploring a deal, said the people cited. Warburg Pincus is said to be weighing its options before taking a call, they Chinese parent has diversified investments that range from healthcare to football clubs, asset management, banks, estate, hospitality, fashion and industrials. The conglomerate has a presence across the pharma value chain from manufacturing to diagnostics and medical devices. Shanghai Fosun Pharmaceutical Co. had acquired an 86% stake in Gland Pharma in 2016 from KKR for a record deal value of $1.26 currently owns 51.8% of Gland, having pared its stake over the years. Market capitalisation has shot up to Rs 32,964.47 crore with the Gland Pharma stock appreciating 10% in the year to date in anticipation of a transaction. It closed Friday at Rs 2,000. In the past month alone, it has shot up 16%. The Fosun stake alone would require a payout of Rs 17,141.28 crore ($1.9 billion).Change of control will involve an open offer for an additional 26% of the company from minority shareholders, making it a much larger transaction. If the open offer is fully subscribed, it would translate to a Rs 25,711 crore ($3 billion) acquisition at current and Gland didn't respond to queries. Brookfield and EQT declined to investors are of the view the stock is overpriced and are interested only at a discount to the current level. 'There are macro headwinds because of industry glut and geopolitics,' said one of the people cited. 'Fosun has to decide if it is okay to sell at a significantly lower price.'This factor could be a deal breaker, analysts said. 'At this level, the process looks tough,' said another industry official. Fosun at various times in recent years, renewed its search for a strategic or financial deal for Gland Pharma. The company ran a full sale process last year but aborted it, only to revive plans earlier this summer, mandating Morgan Stanley and UBS. Mint was first to report that PE interest in Gland had revived in in 1978 by PVN Raju, Gland Pharma develops and manufactures generic injectables for use in nearly 90 countries on five continents, with a focus on the Indian and US markets. As with other Chinese companies, Fosun has faced regulatory issues in India due to the frosty relationship between the two countries. Even its entry into India faced significant delays with deal contours needing tweaks to comply with FDI norms. Some experts said Fosun sees the timing as ideal for an exit. But with no success for years, Fosun has been selling down its shares in the public markets through block deals. Last year, it sold about 6% for ₹1,750 crore. 'The incremental growth for the company's base business in the US is likely to come at the cost of margins,' said Shyam Srinivasan of Goldman management is expecting Cenexi Group — a French injectables and CDMO company Gland acquired in 2023 — to break even by the December quarter. Gland has a toehold in Europe through Cenexi, but rebooting the organisation and its product mix has been analysts said Gland has a sound track record and its future prospects may attract buyers.A veteran industry expert said Gland Pharma has a 'strong compliance history' and its manufacturing quality is impeccable. Plus, a surge in demand is seen for large injectable capacities across the world, making it a good fit. Another strong push for Gland Pharma is the explosive growth in glucagon-like peptide-1(GLP-1) drugs for weight loss and diabetes. Novo Nordisk's Wegovy (semaglutide) is set to go off patent early next year in India and Canada, leading to a burst of generic variants expected to enter the market. This is likely to offset the current overcapacity of injectable assets around the world. Trade tensions between the US and China are adding to the interest in Indian contract manufacturing players for steady supplies. 'Although we have not seen any meaningful switching from China yet, such opportunities cannot be ruled out in the future,' an industry executive is also preparing for a larger play in the biologics business, focusing on expanding its biosimilar and biologic CDMO segment.'The company's collaboration with DRL (Dr Reddy's) and discussions with Henlius (of China) are progressing well, with revenue generation from DRL business expected from FY26,' it said in the presentation.